应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
IMGN ImmunoGen
停牌 02-09 16:00:00 EST
31.23
+0.00
0.00%
最高
31.23
最低
31.23
成交量
0.00
今开
31.23
昨收
31.23
日振幅
0.00%
总市值
87.24亿
流通市值
81.51亿
总股本
2.79亿
成交额
15.18亿
换手率
0.00%
流通股本
2.61亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
【华东医药(000963.SZ):索米妥昔单抗注射液临床试验申请获批准】智通财经APP讯,华东医药(000963.SZ)公告,公司全资子公司杭州中美华东制药有限公司(简称“中美华东”)收到国家药品监督管理局(NMPA)核准签发的《药物临床试验批准通知书》,由中美华东与美国合作方ImmunoGen,Inc.
智通财经 · 04-07
【华东医药(000963.SZ):索米妥昔单抗注射液临床试验申请获批准】智通财经APP讯,华东医药(000963.SZ)公告,公司全资子公司杭州中美华东制药有限公司(简称“中美华东”)收到国家药品监督管理局(NMPA)核准签发的《药物临床试验批准通知书》,由中美华东与美国合作方ImmunoGen,Inc.
【传艾伯维(ABBV.US)拟出售至少130亿美元债券为并购融资】智通财经APP获悉,据知情人士透露,艾伯维(ABBV.US)正寻求出售至少130亿美元的公司债券,为其收购ImmunoGen(IMGN.
智通财经 · 02-22
【传艾伯维(ABBV.US)拟出售至少130亿美元债券为并购融资】智通财经APP获悉,据知情人士透露,艾伯维(ABBV.US)正寻求出售至少130亿美元的公司债券,为其收购ImmunoGen(IMGN.
暂无数据
公司概况
公司名称:
ImmunoGen
所属市场:
NASDAQ
上市日期:
--
主营业务:
ImmunoGen, Inc.于1981年在马萨诸塞州组成,专注于基于抗体的抗癌疗法的研发.该公司利用其 专有的抗体药物共轭技术和ADC技术治疗癌症。ADC技术包含一种抗体,ADC一旦绑定目标,该抗体则连接到癌细胞上,结合它的一个强有力的抗癌剂作为“有效载荷”从而杀死癌细胞。ADC是一种治疗癌症的扩展方法,有两种批准治疗方法以及与过去五年相比翻倍的代理数量。
发行价格:
--
{"stockData":{"symbol":"IMGN","market":"US","secType":"STK","nameCN":"ImmunoGen","latestPrice":31.23,"timestamp":1707512400000,"preClose":31.23,"halted":3,"volume":0,"delay":0,"floatShares":261000000,"shares":279354016,"eps":-0.280028,"marketStatus":"停牌","marketStatusCode":7,"change":0,"latestTime":"02-09 16:00:00 EST","open":31.23,"high":31.23,"low":31.23,"amount":1518209038.257658,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.280028,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1724659200000},"adr":0,"listingDate":627886800000,"adjPreClose":31.23,"adrRate":0,"volumeRatio":0},"requestUrl":"/m/hq/s/IMGN/tweets","defaultTab":"tweets","newsList":[{"id":"2425690720","title":"【华东医药(000963.SZ):索米妥昔单抗注射液临床试验申请获批准】智通财经APP讯,华东医药(000963.SZ)公告,公司全资子公司杭州中美华东制药有限公司(简称“中美华东”)收到国家药品监督管理局(NMPA)核准签发的《药物临床试验批准通知书》,由中美华东与美国合作方ImmunoGen,Inc.","url":"https://stock-news.laohu8.com/highlight/detail?id=2425690720","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2425690720?lang=zh_cn&edition=full","pubTime":"2024-04-07 18:02","pubTimestamp":1712484162,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IMGN","01477","BK0183","BK1576","BK0196","BK1583","03347","BK0188","BK0175","BK0187","BK1574","BK0132","000963","LU2328871848.SGD","BK0209","BK4585","LU1969619763.USD","BK1191","BK1141","BK4139"],"gpt_icon":0},{"id":"2413233589","title":"【传艾伯维(ABBV.US)拟出售至少130亿美元债券为并购融资】智通财经APP获悉,据知情人士透露,艾伯维(ABBV.US)正寻求出售至少130亿美元的公司债券,为其收购ImmunoGen(IMGN.","url":"https://stock-news.laohu8.com/highlight/detail?id=2413233589","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2413233589?lang=zh_cn&edition=full","pubTime":"2024-02-22 09:51","pubTimestamp":1708566696,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BFTCPJ56.SGD","LU0795875086.SGD","LU0029864427.USD","LU0234572021.USD","LU0456855351.SGD","CERE","IE0004445239.USD","IMGN","LU1496350502.SGD","IE0009355771.USD","LU1244550494.USD","LU1989771016.USD","LU0689472784.USD","BK4585","LU0234570918.USD","IE00BJT1NW94.SGD","LU1732799900.SGD","BK4566","LU0158827948.USD","BK4139","BK4581","LU1585245621.USD","LU1244550577.SGD","LU0820561818.USD","LU1839511570.USD","LU1267930490.SGD","LU0198837287.USD","LU0122379950.USD","BK4550","LU0949170772.SGD","LU0128525929.USD","LU0738911758.USD","LU1057294990.SGD","LU1023059063.AUD","LU1291159041.SGD","IE00B2B36J28.USD","LU0912757837.SGD","BK4588","LU0170899867.USD","LU1732800096.USD","LU1430594728.SGD","LU0820561909.HKD","IE00BSNM7G36.USD","BK4559","LU0661504455.SGD","BK4533","ABBV","LU1718418525.SGD","LU1989772923.USD","LU1989772840.SGD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.immunogen.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0.9642},{"period":"ytd","weight":0.0533}],"compareEarnings":[{"period":"1week","weight":0.0141},{"period":"1month","weight":0.0386},{"period":"3month","weight":0.0617},{"period":"6month","weight":0.1069},{"period":"1year","weight":0.2867},{"period":"ytd","weight":0.1827}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"ImmunoGen, Inc.于1981年在马萨诸塞州组成,专注于基于抗体的抗癌疗法的研发.该公司利用其 专有的抗体药物共轭技术和ADC技术治疗癌症。ADC技术包含一种抗体,ADC一旦绑定目标,该抗体则连接到癌细胞上,结合它的一个强有力的抗癌剂作为“有效载荷”从而杀死癌细胞。ADC是一种治疗癌症的扩展方法,有两种批准治疗方法以及与过去五年相比翻倍的代理数量。","yearOnYearQuotes":[{"month":1,"riseRate":0.485714,"avgChangeRate":0.058335},{"month":2,"riseRate":0.4,"avgChangeRate":0.019916},{"month":3,"riseRate":0.294118,"avgChangeRate":-0.02625},{"month":4,"riseRate":0.441176,"avgChangeRate":0.040179},{"month":5,"riseRate":0.558824,"avgChangeRate":0.055439},{"month":6,"riseRate":0.5,"avgChangeRate":0.057736},{"month":7,"riseRate":0.441176,"avgChangeRate":0.001299},{"month":8,"riseRate":0.470588,"avgChangeRate":0.016012},{"month":9,"riseRate":0.441176,"avgChangeRate":0.012768},{"month":10,"riseRate":0.529412,"avgChangeRate":0.011371},{"month":11,"riseRate":0.588235,"avgChangeRate":0.099293},{"month":12,"riseRate":0.457143,"avgChangeRate":-0.000761}],"exchange":"NASDAQ","name":"ImmunoGen","nameEN":"Immunogen"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ImmunoGen(IMGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ImmunoGen(IMGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ImmunoGen,IMGN,ImmunoGen股票,ImmunoGen股票老虎,ImmunoGen股票老虎国际,ImmunoGen行情,ImmunoGen股票行情,ImmunoGen股价,ImmunoGen股市,ImmunoGen股票价格,ImmunoGen股票交易,ImmunoGen股票购买,ImmunoGen股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ImmunoGen(IMGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ImmunoGen(IMGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}